Cutler Group’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Hold |
0
| – | – | – | 1615 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 1831 |
|
|
2023
Q3 | – | Sell |
-1,200
| Closed | -$24K | – | 1871 |
|
|
2023
Q2 | $24K | Hold |
1,200
| – | – | ﹤0.01% | 785 |
|
|
2023
Q1 | $21K | Buy |
1,200
+810
| +208% | +$14.2K | ﹤0.01% | 840 |
|
|
2022
Q4 | $8K | Sell |
390
-110
| -22% | -$2.26K | ﹤0.01% | 1332 |
|
|
2022
Q3 | $13K | Sell |
500
-4,718
| -90% | -$123K | ﹤0.01% | 1309 |
|
|
2022
Q2 | $132K | Buy |
5,218
+4,518
| +645% | +$114K | 0.01% | 594 |
|
|
2022
Q1 | $22K | Buy |
700
+600
| +600% | +$18.9K | ﹤0.01% | 1332 |
|
|
2021
Q4 | $4K | Sell |
100
-100
| -50% | -$4K | ﹤0.01% | 1858 |
|
|
2021
Q3 | $6K | Sell |
200
-600
| -75% | -$18K | ﹤0.01% | 1819 |
|
|
2021
Q2 | $21K | Buy |
800
+300
| +60% | +$7.88K | ﹤0.01% | 1523 |
|
|
2021
Q1 | $14K | Buy |
+500
| New | +$14K | ﹤0.01% | 1552 |
|
|
2020
Q3 | – | Sell |
-100
| Closed | -$2K | – | 2163 |
|
|
2020
Q2 | $2K | Sell |
100
-200
| -67% | -$4K | ﹤0.01% | 1423 |
|
|
2020
Q1 | $4K | Buy |
+300
| New | +$4K | ﹤0.01% | 1238 |
|